Deep dive into co-investments and direct investments, exploring benefits, risks, operational strategies, governance considerations, and real-world applications.
Well, co-investments and direct investments are two alternative investment strategies that have become pretty popular among institutional and high-net-worth investors. You’ve probably heard folks in the industry talking about them like they’re some untapped gold mine or, in some cases, a complicated puzzle. Truth is, both approaches can be powerful ways to enhance returns and reduce fees—but they also carry some unique risks, complexities, and operational hurdles.
Remember how in traditional private equity or hedge fund setups you have a General Partner (GP) making investment decisions and a bunch of Limited Partners (LPs) passively funneling in capital? Co-investments and direct investments basically shake up that structure a bit, giving investors a chance to participate more actively—usually at lower or even zero incremental fees. However, with that comes a need for rapid decision-making, thorough due diligence, and specialized expertise. You’re sort of stepping onto the GP’s playing field.
Below, we’ll dissect the specifics of co-investments, then compare them to direct investments. We’ll look at the pros, cons, operational needs, and a bunch of real-world considerations to help you navigate your own or your firm’s foray into these strategies.
Co-investments commonly allow an LP to invest side by side with a private equity (PE) or hedge fund on a particular deal rather than putting money into an entire fund. For instance, imagine that a PE fund invests in a fast-growing technology startup. If you’re an LP in that fund, you might get the chance for an additional investment—outside of the main fund structure—in that same deal with better economic terms.
Co-investment rights (sometimes spelled out in side letters) give certain LPs the ability to participate in these deals with minimal or no management fees and carried interest. Because the GP remains heavily involved in deal sourcing, due diligence, and ongoing oversight, co-investors leverage the GP’s expertise. However, these offers usually come with an execution window that demands swift decisions—often a matter of days or weeks.
• Lower Overall Fees: By working on a specific transaction outside of the main fund, the LP typically pays reduced management fees and possibly no carried interest.
• Enhanced Returns Potential: There’s often a robust return expectancy here because co-investment deals are selected from the GP’s pipeline, which presumably has been evaluated thoroughly.
• GP Expertise: Co-investors benefit from the GP’s diligent research, negotiation skills, and operational guidance without having to replicate the entire scrutiny process on their own.
• Strategic Influence: In certain cases, co-investors can negotiate board seats or observer roles, giving them more say in driving strategic or governance decisions for the target investment.
• Concentration Risk: A co-investment sometimes involves a significant investment in a single company or project. If this investment goes downhill, it can inflict a pretty big impact on the investor’s portfolio.
• Due Diligence Pressure: Despite leaning on the GP, co-investors must still conduct their own analysis to confirm the deal’s suitability. This must be done fast—sometimes faster than an investor’s typical decision timeline.
• Uneven Allocations: Not all GPs share their top deals across the entire investor base. Some might prefer bigger or more strategic LPs, or they may only share “leftover” deal capacity.
• Liquidity Constraints: Co-investment deals often share the same illiquid nature as private equity: your capital can be locked up for many years, potentially affecting your overall portfolio liquidity.
While co-investments are done alongside a GP, direct investments mean you skip the external fund manager altogether and invest directly in a company, real estate asset, or infrastructure project. Essentially, you become your own mini-GP. You might structure the deal purely on your own or you could partner with other institutional investors who share the same interest.
• Full Control: You make the decisions, from sourcing to negotiations, from capital structure to exit strategy.
• Fee Savings: There’s no second layer of management fees or carried interest because you’re not relying on a fund manager.
• Strategic Alignment: If you’re big on a certain sector or geography, you can target direct investments that align perfectly with your strategic or policy objectives.
• Resource Intensiveness: To do direct investing effectively, you need a specialized team—think in-house investment professionals, legal/corporate staff, maybe even sector experts. And that can be pricey to maintain.
• Operational Complexity: Managing the portfolio company, ensuring compliance, dealing with unexpected operational hurdles—these tasks require significant time and attention.
• Limited Diversification: Allocating big sums in direct deals can hamper your portfolio’s diversification. If you put all your eggs in one basket—say a big direct investment in a single real estate project—and the market slumps, that can be quite painful.
Though both approaches break away from traditional fund investments, the big difference is the involvement of a GP:
If you’re an investor weighing one versus the other, it comes down to your internal capabilities and how fast you need to move. Some LPs prefer to cut their teeth on co-investment deals first, gleaning operational insights from the GP. Others, usually large pension funds or sovereign wealth funds, have the internal muscle to go fully direct.
It’s also worth noting how each channel affects your negotiation leverage. In direct investing, you typically hold a bigger stake and might wield greater control over the board, the terms, and the exit plan. But with co-investments, you usually rely on the GP’s existing structure and network, which can be an advantage if you lack that in-house muscle.
Large institutional investors—pension funds, endowments, insurance companies—often build specialized in-house teams for direct deal sourcing, valuation, and management. That might include:
• Sector Specialists: Individuals with deep knowledge of technology, healthcare, renewable energy, or other areas.
• Legal & Compliance Experts: Direct deals introduce new regulatory and legal complexities.
• Operational Consultants: Professionals who help portfolio companies restructure or implement best practices.
• Risk Management Analysts: Overseeing concentration risk and scenario modeling.
In many ways, building out these capabilities is like creating a private equity firm within your own institution. And, well, that’s neither cheap nor quick. It’s why smaller or mid-sized LPs often can’t—or don’t want to—go full direct.
One of the more exciting aspects of co-investments and direct investments is the reduced layering of fees—at least relative to investing through standard private equity fund structures. With co-investments, management fees can be waived or drastically cut, and the carried interest might be minimal or zero. That obviously helps the net returns for LPs.
However, it’s wise to keep in mind that some GPs may not evenly distribute their “best” deals. There can be real conflicts of interest:
Regulators and industry organizations like the Institutional Limited Partners Association (ILPA) put out best-practice guidelines urging better transparency around deal allocation. But it’s essential for LPs to confirm how these policies work in practice, not just on paper.
At a glance, co-investments and direct investments can shift your portfolio’s liquidity profile—often making it less liquid. If, for instance, you decide to plow $50 million into a single infrastructure project, you’re tying up that capital for an extended timeline. This can be absolutely fine if your overall investment policy statement (IPS) and liability profile permit illiquidity. On the other hand, if you need the flexibility to exit your positions or rebalance, being locked in might cause real headaches.
Some institutional investors handle this by creating separate liquidity pools, ensuring they have enough liquid assets to cover short-term liabilities even if their direct or co-investment holdings are locked up. Others use an approach that sets a firm cap on the total percentage of illiquid holdings.
When it comes to co-investments, you’re reliant on the GP’s due diligence, but you still need your own governance framework to validate deals, terms, and allocations. Just because you’re getting a “great deal” from a GP doesn’t mean you can skip the legwork.
For direct investments, expect an even more robust governance structure. That means having an internal investment committee, a risk oversight committee, and possibly external advisors. Why? Because you no longer can rely on an external GP’s infrastructure and processes. You become both the investor and, in part, the manager.
Moreover, conflict-of-interest policies must be crystal clear. Consider, for example, cross-fund investments. If a GP manages multiple funds, invests them all in the same company, and then offers co-investments to certain LPs, how do you ensure that no group of investors is unfairly disadvantaged? Similar questions arise when an LP invests directly in a company in which one of its GPs also invests, raising the potential for double-dealing or misaligned priorities.
Let’s say Redwood State Pension (RSP) is a large public pension plan with billions under management. They invest in various private equity funds but are looking to reduce overall fees. They decide to accept a GP’s invitation to co-invest in a European software firm.
• Step 1 – Evaluate GP’s Diligence: The GP has already performed vendor due diligence and built a financial model. RSP’s in-house team reviews these materials but also runs their own scenario tests, focusing on worst-case outcomes.
• Step 2 – Deal Terms: RSP negotiates co-investment rights through a side letter, which includes zero management fees and no carry. That’s quite a cost saving.
• Step 3 – Execution Window: The GP demands a quick decision—two weeks. RSP’s internal investment committee (including external advisors) convenes an emergency meeting, reviews the proposed structure, and asks clarifying questions to the GP.
• Step 4 – Decision and Allocations: RSP invests an additional €30 million, which sits outside of the pension’s main commitment in the GP’s broader fund. Over the next five years, the investment either outperforms or underperforms, but the net return stands a good chance of beating what it would have been if RSP only had exposure via the main PE fund.
The moral of the story: RSP leverages the GP’s expertise, pays fewer fees, but takes on extra diligence and a narrower exposure risk.
Below is a simple schematic that shows how co-investors, GPs, and target companies often interconnect:
flowchart LR A["Limited Partner (Co-Investor)"] --> B["Co-Investment Vehicle"] B --> C["Target Company"] D["GP / Fund Manager"] --> C A --> D["Existing LP <br/> Commitment"]
In this diagram:
• The co-investment vehicle (sometimes just a special-purpose entity) channels the LP’s additional capital directly into the target company.
• The GP invests through its main fund.
• The co-investor has a separate direct exposure, albeit still relying partly on the GP’s expertise.
If you recall from earlier chapters, especially in risk management discussions (see Chapter 6: Introduction to Risk Management), illiquidity can hamper your ability to weather unexpected cash flow needs. So it’s crucial to:
• Set Hard Limits on Illiquid Investments: For example, a policy might say, “No more than 20% of total assets in co-investments or direct deals.”
• Monitor Potential Concentration Buildup: Because co-investments or direct investments are typically larger lumps of capital in single assets, you might exceed your internal guidelines if you’re not paying attention.
• Stress Testing: Evaluate how these positions would behave under extreme market conditions. Possibly use advanced scenario analysis or VaR-like metrics to gauge worst-case capital drawdowns.
Sometimes, it’s helpful to compare the net return of a co-investment to what you might get if you only invested through the main fund.
Let’s say the GP’s main fund charges a 1.5% management fee per year and 20% carry after crossing an 8% hurdle. Your co-investment, on the other hand, charges 0% management fee and 5% carry. For simplicity, assume a 5-year horizon and a gross IRR of 15%.
• Under the main fund structure, net IRR might drop to around 12% (because of the management fee drag and 20% carry).
• Under the co-investment terms, net IRR might stay closer to 14% or so (minimal fees reduce the drag).
The difference of ~2% annualized might not sound enormous, but over five years, that can translate into a significant boost in final cash flows.
In KaTeX form, if we let \( IRR_{gross} \) be the gross internal rate of return, and \( f \) be the fee drag plus carried interest impact, then:
Under co-investment terms, \( f \) is typically smaller (less or zero management fee, lower carry), so \( IRR_{net} \) can be substantially higher compared to standard fund terms.
• Data Interpretation: In scenario-based questions, watch for small details like fee structures, time horizon, and liquidity constraints.
• Risk vs. Return: The exam might test your ability to weigh the risk of concentration versus the benefit of lower fees in a co-investment scenario.
• Decision Timing: Be ready to describe how you’d handle compressed deal windows—these items pop up in both item sets and essay questions.
• Governance: Emphasize the need for oversight committees, conflict-of-interest disclosures, and robust due diligence.
• GP (General Partner): The managing entity of a private equity or hedge fund, responsible for key decisions and daily operations.
• Co-Investment Rights: Formal or informal arrangements that permit LPs to invest additional money into specific deals beyond their original fund commitment.
• Concentration Risk: A hazard resulting from placing a large portion of capital into a single deal or asset.
• Side Letter: An agreement offering specialized terms to an investor, often covering co-investment rights or fee concessions.
• Execution Window: The narrow timeframe an LP has to decide on a co-investment deal.
• Direct Deal Flow: The pipeline of potential direct investment targets, typically sourced by an in-house team or third-party networks.
• Cross-Fund Investment: When multiple funds controlled by the same GP invest in the same company, prompting potential oversight issues.
• Fee Specials: Customized fee terms for large or strategically significant investors (e.g., no management fees on co-investments).
Important Notice: FinancialAnalystGuide.com provides supplemental CFA study materials, including mock exams, sample exam questions, and other practice resources to aid your exam preparation. These resources are not affiliated with or endorsed by the CFA Institute. CFA® and Chartered Financial Analyst® are registered trademarks owned exclusively by CFA Institute. Our content is independent, and we do not guarantee exam success. CFA Institute does not endorse, promote, or warrant the accuracy or quality of our products.